SUSAN CLAVETTE: Open Payments
NPI 1770903114 · OVERLAND PARK, KS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,833 in 104 payments from 15 companies in 2025. Trend: 2023 $1,744 · 2024 $2,254 · 2025 $1,833
Food & beverage: $1,763Education: $70
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 19 | $265 |
| Lundbeck LLC | 13 | $251 |
| E.R. Squibb & Sons, L.L.C. | 13 | $209 |
| Teva Pharmaceuticals USA, Inc. | 7 | $197 |
| Takeda Pharmaceuticals U.S.A., Inc. | 11 | $168 |
| Collegium Pharmaceutical, Inc. | 11 | $144 |
| Almatica Pharma LLC | 11 | $143 |
| Supernus Pharmaceuticals, Inc. | 4 | $134 |
| HARMONY BIOSCIENCES LLC | 3 | $112 |
| Axsome Therapeutics, Inc. | 5 | $98 |
Products named: REXULTI, COBENFY, AUSTEDO XR, TRINTELLIX, Jornay PM, LOREEV XR, Qelbree, NUEDEXTA.
Industry payments across KS — which companies pay providers there.
